XML 57 R41.htm IDEA: XBRL DOCUMENT
v3.24.3

Stock-Based Compensation (Tables) | 12 Months Ended
--- | ---
Oct. 27, 2024
Share-Based Payment Arrangement [Abstract] |
Schedule of reconciliation of the number of options outstanding and exercisable | A reconciliation of the number of options outstanding and exercisable as of October 27, 2024, is:
|  | Shares (in thousands) |  | Weighted-average Exercise Price |  | Weighted-average Remaining Contractual Term (Years) |  | Aggregate Intrinsic Value (in thousands)
Stock Options Outstanding at October 29, 2023 |  | 16,384 |  |  | $ | 37.61 |  |  |  |  |
Granted |  | 1,757 |  |  | 31.46 |  |  |  |  |
Exercised |  | (1,827) |  |  | 24.28 |  |  |  |  |
Forfeited |  | (61) |  |  | 42.74 |  |  |  |  |
Expired |  | (259) |  |  | 37.94 |  |  |  |  |
Stock Options Outstanding at October 27, 2024 |  | 15,994 |  |  | $ | 38.43 |  |  | 4.4 |  | $ | 5,547 |
Stock Options Exercisable at October 27, 2024 |  | 12,641 |  |  | $ | 38.51 |  |  | 3.3 |  | $ | 5,451 |
Schedule of weighted-average grant date fair value of stock options granted and the total intrinsic value of options exercised | The weighted-average grant date fair value of stock options granted and the total intrinsic value of options exercised are:
|  | Fiscal Year Ended
In thousands, except per share amounts |  | October 27, 2024 |  | October 29, 2023 |  | October 30, 2022
Weighted-average Grant Date Fair Value |  | $ | 5.95 |  |  | $ | 10.06 |  |  | $ | 7.09 |
Intrinsic Value of Exercised Options |  | 16,259 |  |  | 6,350 |  |  | 109,745 |
Schedule of weighted-average assumptions used to calculate fair value of each option award | The fair value of each option award is calculated on the date of grant using the Black-Scholes valuation model utilizing the following weighted-average assumptions:
|  | Fiscal Year Ended
|  | October 27, 2024 |  | October 29, 2023 |  | October 30, 2022
Risk-free Interest Rate |  | 4.1 | % |  | 3.5 | % |  | 1.6 | %
Dividend Yield |  | 3.6 | % |  | 2.4 | % |  | 2.4 | %
Stock Price Volatility |  | 21.5 | % |  | 21.1 | % |  | 20.4 | %
Expected Option Life |  | 7.5 years |  | 7.4 years |  | 7.5 years
Schedule of reconciliation of the nonvested shares | A reconciliation of the restricted stock units as of October 27, 2024, is:
|  | Shares (in thousands) |  | Weighted- average Grant Date Fair Value | Weighted-average Remaining Contractual Term (Years) | Aggregate Intrinsic Value (in thousands)
Restricted Stock Units Outstanding at October 29, 2023 |  | 723 |  |  | $ | 45.59 |  |  |
Granted |  | 394 |  |  | 31.39 |  |  |
Dividend Equivalents |  | 29 |  |  | 34.94 |  |  |
Vested |  | (245) |  |  | 44.78 |  |  |
Forfeited |  | (18) |  |  | 43.63 |  |  |
Restricted Stock Units Outstanding at October 27, 2024 |  | 882 |  |  | $ | 39.22 |  | 1.3 | $ | 27,391 |
A reconciliation of the restricted shares as of October 27, 2024, is:
|  | Shares (in thousands) |  | Weighted- average Grant Date Fair Value
Restricted Shares Outstanding at October 29, 2023 |  | 44 |  |  | $ | 44.14 |
Granted |  | 54 |  |  | 30.89 |
Vested |  | (35) |  |  | 45.34 |
Forfeited |  | (9) |  |  | 34.44
Restricted Shares Outstanding at October 27, 2024 |  | 53 |  |  | $ | 31.51 |
Schedule of the weighted-average grant date fair value and fair value of nonvested shares granted | The weighted-average grant date fair value of restricted stock units granted, the total fair value of restricted stock units granted, and the fair value of restricted stock units that have vested are:
|  | Fiscal Year Ended
In thousands, except per share amounts |  | October 27, 2024 |  | October 29, 2023 |  | October 30, 2022
Weighted-average Grant Date Fair Value |  | $ | 31.39 |  |  | $ | 45.96 |  |  | $ | 44.14 |
Fair Value of Restricted Stock Units Granted |  | 12,355 |  |  | 10,889 |  |  | 15,980 |
Fair Value of Restricted Stock Units Vested |  | 10,988 |  |  | 8,466 |  |  | 1,893 |
The weighted-average grant date fair value of restricted shares granted, the total fair value of restricted shares granted, and the fair value of shares that have vested are:
|  | Fiscal Year Ended
In thousands, except per share amounts |  | October 27, 2024 |  | October 29, 2023 |  | October 30, 2022
Weighted-average Grant Date Fair Value |  | $ | 30.89 |  |  | $ | 44.14 |  |  | $ | 47.11 |
Fair Value of Restricted Shares Granted |  | 1,680 |  |  | 1,920 |  |  | 1,760 |
Fair Value of Restricted Shares Vested |  | 1,600 |  |  | 1,760 |  |  | 1,760 |

X
- Definition Tabular disclosure of the weighted-average grant-date fair value of stock options granted during the period, and total intrinsic value of options exercised in the period. + References No definition available. + Details
Name: | hrl_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueAndIntrinsicValueOfExercisedOptionsTableTextBlock
Namespace Prefix: | hrl_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the weighted-average grant date fair value of nonvested shares granted, the total fair value of nonvested shares granted, and the fair value of nonvested shares that have vested during the period. + References No definition available. + Details
Name: | hrl_ScheduleOfWeightedAverageGrantDateFairValueAndFairValueNonvestedSharesGrantedAndVestedTableTextBlock
Namespace Prefix: | hrl_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration